To provide an external validation for our findings, we interrogated the Cancer Cell Line Encyclopedia (Broad, 2019) via cBioPortal13-16 for NSCLC cell lines harboring BRAF class 3 mutations. This evidence concerns the gene BRAF and non-small cell lung carcinoma.